Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection

被引：14

作者：

BenAri, Z

Shmueli, D

Mor, E

Shaharabani, E

BarNathan, N

Shapira, Z

TurKaspa, R

机构：

[1] RABIN MED CTR,DEPT MED D,IL-49100 PETAH TIQWA,ISRAEL

[2] RABIN MED CTR,DEPT TRANSPLANTAT,IL-49100 PETAH TIQWA,ISRAEL

[3] RABIN MED CTR,DEPT SURG B,IL-49100 PETAH TIQWA,ISRAEL

[4] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL

来源：

TRANSPLANTATION PROCEEDINGS | 1997年 / 29卷 / 06期

关键词：

D O I：

10.1016/S0041-1345(97)00556-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2687 / 2688

页数：2

共 14 条

[1]

ANGUS PW, 1995, HEPATOLOGY, V21, P14, DOI 10.1016/0270-9139(95)90401-8

[2] Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation [J].

Bain, VG ;

Kneteman, NM ;

Ma, MM ;

Gutfreund, K ;

Shapiro, JA ;

Fischer, K ;

Tipples, G ;

Lee, H ;

Jewell, LD ;

Tyrrell, DL .

TRANSPLANTATION, 1996, 62 (10) :1456-1462

[3] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[4] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[5] Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis [J].

Grellier, L ;

Mutimer, D ;

Ahmed, M ;

Brown, D ;

Burroughs, AK ;

Rolles, K ;

McMaster, P ;

Beranek, P ;

Kennedy, F ;

Kibbler, H ;

McPhillips, P ;

Elias, E ;

Dusheiko, G .

LANCET, 1996, 348 (9036) :1212-1215

[6] LONG-TERM FOLLOW-UP OF HEPATITIS-B VIRUS-INFECTED RECIPIENTS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION [J].

KONIG, V ;

HOPF, U ;

NEUHAUS, P ;

BAUDITZ, J ;

SCHMIDT, CA ;

BLUMHARDT, G ;

BECHSTEIN, WO ;

NEUHAUS, R ;

LOBECK, H .

TRANSPLANTATION, 1994, 58 (05) :553-559

[7] UNUSUALLY RAPID DEVELOPMENT OF A HBSAG-POSITIVE LIVER-CIRRHOSIS AFTER LIVER-TRANSPLANTATION [J].

LAUTZ, HU ;

MULLER, R ;

WITTEKIND, C ;

MAUZ, S ;

BARGHOCK, H ;

RINGE, B ;

PICHLMAYR, R ;

SCHMIDT, FW .

KLINISCHE WOCHENSCHRIFT, 1989, 67 (20) :1061-1065

[8] PRETRANSPLANTATION INTERFERON TREATMENT AND RECURRENCE OF HEPATITIS-B VIRUS-INFECTION AFTER LIVER-TRANSPLANTATION FOR HEPATITIS-B RELATED END-STAGE LIVER-DISEASE [J].

MARCELLIN, P ;

SAMUEL, D ;

AREIAS, J ;

LORIOT, MA ;

ARULNADEN, JL ;

GIGOU, M ;

DAVID, MF ;

BISMUTH, A ;

REYNES, M ;

BRECHOT, C ;

BENHAMOU, JP ;

BISMUTH, H .

HEPATOLOGY, 1994, 19 (01) :6-12

[9] LIVER-TRANSPLANTATION IN HBS-ANTIGEN (HBSAG) CARRIERS - PREVENTION OF HEPATITIS-B VIRUS (HBV) RECURRENCE BY PASSIVE-IMMUNIZATION [J].

MULLER, R ;

GUBERNATIS, G ;

FARLE, M ;

NIEHOFF, G ;

KLEIN, H ;

WITTEKIND, C ;

TUSCH, G ;

LAUTZ, HU ;

BOKER, K ;

STANGEL, W ;

PICHLMAYR, R .

JOURNAL OF HEPATOLOGY, 1991, 13 (01) :90-96

[10]

OGRADY JG, 1992, J HEPATOL, V14, P64

← 1 2 →